Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murthy, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murthy, R.
(Chest. 2001;119:405S-411S.)
© 2001 American College of Chest Physicians

Implementation of Strategies to Control Antimicrobial Resistance*

Rekha Murthy, MD

* From the Division of Infectious Diseases, Cedars-Sinai Medical Center, University of California, Los Angeles, Los Angeles, CA.

Correspondence to: Rekha Murthy, MD, Director, Hospital Epidemiology, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Room: MOT 1130E, Los Angeles, CA 90048

Antimicrobial resistance has emerged as a major public health issue in recent years. A steady increase in resistance continues despite the introduction of new antibiotics, and resistant bacteria have been associated with increased patient morbidity and mortality as well as with increased costs. Addressing the problem of antimicrobial resistance requires both infection control and regulation of antibiotic use; addressing either alone is insufficient. Mounting evidence shows that control of the use of broad-spectrum antibiotics (especially vancomycin and third-generation cephalosporins) and implementation of infection control measures can result in decreased incidence of antibiotic-resistant bacteria such as vancomycin-resistant enterococci and extended-spectrum ß-lactamase–producing Escherichia coli and Klebsiella. Recent reports from professional organizations and a consensus of experts have outlined strategies for the control of resistance in hospitals, with specific measures identified for antibiotic control and infection control. These reports have emphasized the importance of a multidisciplinary approach in tackling this problem in hospitals and have suggested that a quality-improvement model be used to address antimicrobial resistance. A close collaboration among the disciplines of infectious diseases, microbiology, hospital epidemiology, pharmacy, and nursing, with particular emphasis in ICUs, and with strong support from hospital leadership, can result in an effective program that can be readily incorporated into the quality-improvement goals of any health-care organization.

Key Words: antibiotics • drug resistance • ICUs • vancomycin




This article has been cited by other articles:


Home page
Environment and BehaviorHome page
H. Chaudhury, A. Mahmood, and M. Valente
Advantages and Disadvantages of Single-Versus Multiple-Occupancy Rooms in Acute Care Environments: A Review and Analysis of the Literature
Environment and Behavior, November 1, 2005; 37(6): 760 - 786.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
T. B. Giblin, R. L. Sinkowitz-Cochran, P. L. Harris, S. Jacobs, K. Liberatore, M. A. Palfreyman, E. I. Harrison, D. M. Cardo, and for the CDC Campaign to Prevent Antimicrobial Resi
Clinicians' Perceptions of the Problem of Antimicrobial Resistance in Health Care Facilities
Arch Intern Med, August 9, 2004; 164(15): 1662 - 1668.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Chest Physicians.